PE20070332A1 - Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas - Google Patents
Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasasInfo
- Publication number
- PE20070332A1 PE20070332A1 PE2006001056A PE2006001056A PE20070332A1 PE 20070332 A1 PE20070332 A1 PE 20070332A1 PE 2006001056 A PE2006001056 A PE 2006001056A PE 2006001056 A PE2006001056 A PE 2006001056A PE 20070332 A1 PE20070332 A1 PE 20070332A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- heteroaryl
- inhibitors
- alkylen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05381043 | 2005-09-02 | ||
EP06110666 | 2006-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070332A1 true PE20070332A1 (es) | 2007-05-11 |
Family
ID=37770277
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001057A PE20070612A1 (es) | 2005-09-02 | 2006-08-31 | Nuevos inhibidores de cisteina proteasas |
PE2006001056A PE20070332A1 (es) | 2005-09-02 | 2006-08-31 | Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001057A PE20070612A1 (es) | 2005-09-02 | 2006-08-31 | Nuevos inhibidores de cisteina proteasas |
Country Status (4)
Country | Link |
---|---|
AR (2) | AR055624A1 (fr) |
PE (2) | PE20070612A1 (fr) |
TW (2) | TW200804351A (fr) |
WO (3) | WO2007025774A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2030621A1 (fr) * | 2007-08-21 | 2009-03-04 | Glaxo Group Limited | Nouveaux pyrimidines comme inhibiteurs de la cystéine protéase |
JP2010508322A (ja) * | 2006-10-30 | 2010-03-18 | グラクソ グループ リミテッド | システインプロテアーゼ阻害薬としての新規置換ピリジン誘導体 |
EP2168600A1 (fr) | 2007-06-08 | 2010-03-31 | Nippon Chemiphar Co., Ltd. | Agent thérapeutique ou prophylactique contre l'anévrisme cérébral |
JPWO2009054454A1 (ja) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | カテプシン阻害剤を有効成分として含有するToll様受容体のシグナル伝達の調整剤 |
DE102008063561A1 (de) * | 2008-12-18 | 2010-08-19 | Bayer Cropscience Ag | Hydrazide, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Insektizide |
CN102267964B (zh) * | 2011-06-15 | 2014-06-18 | 浙江师范大学 | 3-羟基-2,3-二氢苯并呋喃衍生物及其合成方法和应用 |
EP3778576B1 (fr) * | 2018-03-28 | 2024-04-17 | Hanlim Pharmaceutical Co., Ltd. | Dérivé de 2-cyanopyrimidin-4-yl carbamate ou d'urée ou sel de celui-ci et composition pharmaceutique le comprenant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036375A1 (es) * | 2001-08-30 | 2004-09-01 | Novartis Ag | Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos |
-
2006
- 2006-08-31 AR ARP060103810A patent/AR055624A1/es not_active Application Discontinuation
- 2006-08-31 TW TW095132087A patent/TW200804351A/zh unknown
- 2006-08-31 WO PCT/EP2006/008578 patent/WO2007025774A2/fr active Application Filing
- 2006-08-31 WO PCT/EP2006/008579 patent/WO2007025775A2/fr active Application Filing
- 2006-08-31 PE PE2006001057A patent/PE20070612A1/es not_active Application Discontinuation
- 2006-08-31 PE PE2006001056A patent/PE20070332A1/es not_active Application Discontinuation
- 2006-08-31 AR ARP060103809A patent/AR057110A1/es not_active Application Discontinuation
- 2006-08-31 TW TW095132088A patent/TW200804352A/zh unknown
- 2006-08-31 WO PCT/EP2006/008580 patent/WO2007025776A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007025774A2 (fr) | 2007-03-08 |
AR057110A1 (es) | 2007-11-14 |
WO2007025774A3 (fr) | 2007-04-26 |
WO2007025776A3 (fr) | 2007-05-03 |
TW200804351A (en) | 2008-01-16 |
WO2007025776A2 (fr) | 2007-03-08 |
TW200804352A (en) | 2008-01-16 |
WO2007025775A2 (fr) | 2007-03-08 |
PE20070612A1 (es) | 2007-06-23 |
AR055624A1 (es) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070332A1 (es) | Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas | |
PE20081471A1 (es) | Derivados de heteroarilnitrilo como inhibidores de cisteina proteasa | |
ATE427932T1 (de) | 11beta-hsd1-inhibitoren | |
CO5690568A2 (es) | Agonismo del receptor de 5ht2a para el tratamiento de disfun cion termorreguladora | |
ES2570599T3 (es) | Composición suave para desinfección cutánea | |
UY29246A1 (es) | Nuevos compuestos | |
UY28897A1 (es) | Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb | |
PE20071223A1 (es) | Procedimiento de preparacion de derivados de acil-amino-alquilen-amida | |
GT200600246A (es) | Formulacion de 1-[(3-hidroxi-adamant-1-ilamino)-acetil]-pirrolidin-2(s)-carbonitrilo de liberacion modificada | |
UY29016A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
PE20070541A1 (es) | Compuestos y composiciones que comprenden isoindol-imidas | |
PE20060479A1 (es) | Compuestos heteroaril-aril-ureas como inhibidores de la quinasa | |
EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
AR092774A1 (es) | Composicion de limpieza que comprende variantes de amilasa con alta estabilidad en la presencia de un agente quelante | |
UY30440A1 (es) | Nuevos compuestos | |
CO6160301A2 (es) | Preparacion solida que contiene alogliptina y clorhidrato de metformina | |
PE20121157A1 (es) | Compuestos heterociclicos como inhibidores de proteasas serinas | |
UY28821A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos. | |
AR054790A1 (es) | Metodos para el tratamiento de disfuncion sexual | |
NO20063944L (no) | Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister | |
PE20080843A1 (es) | Inhibidores de renina y metodo para su utilizacion | |
SV2008002958A (es) | Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania referencia cruzada ref. prd2592sv | |
BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |